OncoMed Pharmaceuticals Inc — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d8e517bc-1739-4441-b096-4f3829fa98ad/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | $-10.0M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006795 |
| FY 2017 | $-41.0M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005014 |
| FY 2016 | $-103.4M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-003874 |
| FY 2015 | $-85.6M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-014426 |
| FY 2014 | $-50.6M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-089346 |
| FY 2013 | $-23.9M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-104564 |
| FY 2012 | $-22.4M | 2012-01-01 – 2012-12-31 | evidence 0001193125-14-104564 |
| FY 2011 | $-15.2M | 2011-01-01 – 2011-12-31 | evidence 0001193125-14-104564 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
OncoMed Pharmaceuticals Inc — all facts · Revenue · Net Income